Clinical Trial Update: Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 clinical trial assessing the impact of GLP-1 on insulin dose, hypoglycemia risk, and gastric emptying in adults with Type 1 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED